Evaluating the evidence for sacubitril/valsartan across the continuum of heart failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating the evidence for sacubitril/valsartan across the continuum of heart failure

Published:2022-10-07 Issue:11 Volume:42 Page:837-848
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Skersick Preston T.¹²,Proco Darrian²,Sharma‐Huynh Preetika³,Montepara Courtney A.⁴^ORCID,Rodgers Jo E.¹^ORCID

Affiliation:

1. UNC Eshelman School of Pharmacy University of North Carolina Chapel Hill North Carolina USA

2. GlaxoSmithKline Research Triangle Park Durham North Carolina USA

3. PPD Morrisville North Carolina USA

4. Duquesne University School of Pharmacy Duquesne University Pittsburgh Pennsylvania USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2730

Reference42 articles.

1. Heart Failure: Diagnosis, Management and Utilization

2. Heart Disease and Stroke Statistics—2021 Update

3. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

4. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

5. FDA Approves New Heart Failure Drug.Latest in cardiology– American College of Cardiology.https://www.acc.org/latest‐in‐cardiology/articles/2015/07/08/10/00/fda‐approves‐new‐heart‐failure‐drug. Accessed August 30 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP